首页 > 最新文献

Congestive heart failure最新文献

英文 中文
Advancing the Advances in Heart Failure: Updates on Newer Therapies 心力衰竭的进展:新疗法的更新
Pub Date : 2005-07-01 DOI: 10.1111/J.1527-5299.2005.04779.X
M. Silver
Marc A. Silver, MD, Co-Editor in Chief From the Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL Address for correspondence: Marc A. Silver, MD, Chairman and Clinical Professor, Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, 4440 West 95th Street, Suite 319 South, Oak Lawn, IL 60453-2600 E-mail: marc.silver@advocatehealth.com In January 2005, we issued a call for papers to focus on updates on some of the new and emerging therapies for patients with heart failure. We specifically asked potential authors to focus on biventricular resynchronization and left ventricular assist devices. This focus was prudent, because although clinical trial publications and early adoption of these strategies were of recent vintage, we felt that these were two key therapeutic areas where the field was evolving on a daily basis. Furthermore, as a heart failure community, we must test our tools every day. There is no room here for a strategy or therapy that does not provide continued significant improvement in heart failure outcomes for patients. So the call went out and authors responded. Included in this issue are four of these papers. One deals with updates on selecting responders to resynchronization therapy—a hot topic indeed. Two others deal with advances in patient selection and care for potential left ventricular assist device recipients and potential new complications to be aware of. We are also pleased to have the excellent paper by Faris and colleagues representing an important FDA perspective on both resynchronization and left ventricular assist devices. And as these papers are published, it is my hope that they soon become obsolete. We should push ourselves to test the methods and resources we use for heart failure patients every day. We should continue to speak among ourselves and to others about these advances. In that context, Congestive Heart Failure will continue to publish periodic focus issues like this. In an electronic age, we should be able to spread best practices liberally to those who provide the care; it is our pledge to be part of that dissemination of current knowledge.
马克·a·西尔弗,医学博士,联合主编来自医学系和心力衰竭研究所,倡导基督医疗中心,橡树草坪,IL通信地址:马克·a·西尔弗,医学博士,医学和心力衰竭研究所系主任和临床教授,倡导基督医疗中心,西95街4440号,套房319南,橡树草坪,IL 60453-2600电子邮件:marc.silver@advocatehealth.com在2005年1月,我们发布了一项论文征集,聚焦于一些新的和新兴的治疗心力衰竭的方法。我们特别要求潜在的作者关注双心室再同步和左心室辅助装置。这种关注是谨慎的,因为尽管临床试验出版物和这些策略的早期采用是最近的,但我们认为这是该领域每天都在发展的两个关键治疗领域。此外,作为一个心力衰竭社区,我们必须每天测试我们的工具。对于不能持续显著改善心力衰竭患者预后的策略或治疗,我们没有立足之地。于是这个号召发出了,作者们也回应了。本期将收录其中的四篇论文。其中一篇是关于选择再同步治疗应答者的最新进展——这确实是一个热门话题。另外两篇涉及到患者选择和护理的进展,潜在的左心室辅助装置接受者和潜在的新并发症要注意。我们也很高兴Faris及其同事发表了一篇优秀的论文,代表了FDA对再同步化和左心室辅助装置的重要观点。随着这些论文的发表,我希望它们很快就会过时。我们应该督促自己每天测试治疗心力衰竭患者的方法和资源。我们应该继续在我们自己和其他人之间谈论这些进步。在这样的背景下,《充血性心力衰竭》将继续定期出版这样的焦点问题。在电子时代,我们应该能够将最佳实践自由地传播给提供护理的人;我们保证成为传播当前知识的一部分。
{"title":"Advancing the Advances in Heart Failure: Updates on Newer Therapies","authors":"M. Silver","doi":"10.1111/J.1527-5299.2005.04779.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2005.04779.X","url":null,"abstract":"Marc A. Silver, MD, Co-Editor in Chief From the Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL Address for correspondence: Marc A. Silver, MD, Chairman and Clinical Professor, Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, 4440 West 95th Street, Suite 319 South, Oak Lawn, IL 60453-2600 E-mail: marc.silver@advocatehealth.com In January 2005, we issued a call for papers to focus on updates on some of the new and emerging therapies for patients with heart failure. We specifically asked potential authors to focus on biventricular resynchronization and left ventricular assist devices. This focus was prudent, because although clinical trial publications and early adoption of these strategies were of recent vintage, we felt that these were two key therapeutic areas where the field was evolving on a daily basis. Furthermore, as a heart failure community, we must test our tools every day. There is no room here for a strategy or therapy that does not provide continued significant improvement in heart failure outcomes for patients. So the call went out and authors responded. Included in this issue are four of these papers. One deals with updates on selecting responders to resynchronization therapy—a hot topic indeed. Two others deal with advances in patient selection and care for potential left ventricular assist device recipients and potential new complications to be aware of. We are also pleased to have the excellent paper by Faris and colleagues representing an important FDA perspective on both resynchronization and left ventricular assist devices. And as these papers are published, it is my hope that they soon become obsolete. We should push ourselves to test the methods and resources we use for heart failure patients every day. We should continue to speak among ourselves and to others about these advances. In that context, Congestive Heart Failure will continue to publish periodic focus issues like this. In an electronic age, we should be able to spread best practices liberally to those who provide the care; it is our pledge to be part of that dissemination of current knowledge.","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"18 1","pages":"176-176"},"PeriodicalIF":0.0,"publicationDate":"2005-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88733841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. Short-Term Risk of Death After Treatment With Nesiritide for Decompensated Heart Failure 心脏再同步化对心力衰竭发病率和死亡率的影响。奈西立肽治疗失代偿性心力衰竭后的短期死亡风险
Pub Date : 2005-01-01 DOI: 10.1111/j.1527-5299.2005.04176.x
I. S. Virk, John Ip
{"title":"The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. Short-Term Risk of Death After Treatment With Nesiritide for Decompensated Heart Failure","authors":"I. S. Virk, John Ip","doi":"10.1111/j.1527-5299.2005.04176.x","DOIUrl":"https://doi.org/10.1111/j.1527-5299.2005.04176.x","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"236 1","pages":"216-218"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82441990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Insulin Ameliorates Exercise Ventilatory Efficiency and Oxygen Uptake in Patients With Heart Failure-Type 2 Diabetes Comorbidity 胰岛素改善心力衰竭合并2型糖尿病患者的运动通气效率和摄氧量
Pub Date : 2003-11-01 DOI: 10.1111/J.1527-5299.2003.02318.X
M. Kamboj, S. Kantipudi, Atul Khasais, R. Thakur
{"title":"Insulin Ameliorates Exercise Ventilatory Efficiency and Oxygen Uptake in Patients With Heart Failure-Type 2 Diabetes Comorbidity","authors":"M. Kamboj, S. Kantipudi, Atul Khasais, R. Thakur","doi":"10.1111/J.1527-5299.2003.02318.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2003.02318.X","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"1 1","pages":"347-348"},"PeriodicalIF":0.0,"publicationDate":"2003-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79847321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry. β -受体阻滞剂在社区黑人心力衰竭患者中的耐受性、安全性和有效性:来自大型前瞻性β -受体阻滞剂登记的见解
Pub Date : 2003-10-01 DOI: 10.1016/S0735-1097(04)91775-5
W. Abraham, B. Massie, M. Lukas, S. Lottes, J. Nelson, M. Fowler, B. Greenberg, E. Gilbert, J. Franciosa
{"title":"Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.","authors":"W. Abraham, B. Massie, M. Lukas, S. Lottes, J. Nelson, M. Fowler, B. Greenberg, E. Gilbert, J. Franciosa","doi":"10.1016/S0735-1097(04)91775-5","DOIUrl":"https://doi.org/10.1016/S0735-1097(04)91775-5","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"14 1","pages":"16-21"},"PeriodicalIF":0.0,"publicationDate":"2003-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77995045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Effect of Orlistat in obese patients with heart failure: a pilot study. 奥利司他对肥胖心衰患者的影响:一项初步研究。
Pub Date : 2003-10-01 DOI: 10.1016/S1071-9164(03)00167-2
L. Beck-da-Silva, L. Higginson, M. Fraser, K. Williams, H. Haddad
{"title":"Effect of Orlistat in obese patients with heart failure: a pilot study.","authors":"L. Beck-da-Silva, L. Higginson, M. Fraser, K. Williams, H. Haddad","doi":"10.1016/S1071-9164(03)00167-2","DOIUrl":"https://doi.org/10.1016/S1071-9164(03)00167-2","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"10 13 1","pages":"118-23"},"PeriodicalIF":0.0,"publicationDate":"2003-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87234882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 41
Association of Consultation Between Generalists and Cardiologists With Quality and Outcomes of Heart Failure Care 通才和心脏病专家会诊与心力衰竭护理质量和结果的关联
Pub Date : 2003-07-01 DOI: 10.1111/j.1527-5299.2003.02312.x
D. Tepper
{"title":"Association of Consultation Between Generalists and Cardiologists With Quality and Outcomes of Heart Failure Care","authors":"D. Tepper","doi":"10.1111/j.1527-5299.2003.02312.x","DOIUrl":"https://doi.org/10.1111/j.1527-5299.2003.02312.x","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"22 1","pages":"230-231"},"PeriodicalIF":0.0,"publicationDate":"2003-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86457268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
CME in CHF 以瑞郎计的CME
Pub Date : 2003-05-01 DOI: 10.1111/J.1527-5299.2003.02572.X
M. Silver
{"title":"CME in CHF","authors":"M. Silver","doi":"10.1111/J.1527-5299.2003.02572.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2003.02572.X","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"3 1","pages":"125-125"},"PeriodicalIF":0.0,"publicationDate":"2003-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80765148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Randomized Comparison of Enoxaparin With Unfractionated Heparin for the Prevention of Venous Thromboembolism in Medical Patients With Heart Failure or Severe Respiratory Disease 依诺肝素与未分离肝素预防心力衰竭或严重呼吸系统疾病内科患者静脉血栓栓塞的随机比较
Pub Date : 2003-05-01 DOI: 10.1111/J.1527-5299.2003.02309.X
D. Tepper
{"title":"Randomized Comparison of Enoxaparin With Unfractionated Heparin for the Prevention of Venous Thromboembolism in Medical Patients With Heart Failure or Severe Respiratory Disease","authors":"D. Tepper","doi":"10.1111/J.1527-5299.2003.02309.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2003.02309.X","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"1 1","pages":"179-180"},"PeriodicalIF":0.0,"publicationDate":"2003-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86514561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 36
Clinical Outcomes in Patients on Beta‐Blocker Therapy Admitted With Worsening Chronic Heart Failure 慢性心力衰竭加重患者接受受体阻滞剂治疗的临床结果
Pub Date : 2003-03-01 DOI: 10.1111/J.1527-5299.2003.01904.X
D. Tepper
{"title":"Clinical Outcomes in Patients on Beta‐Blocker Therapy Admitted With Worsening Chronic Heart Failure","authors":"D. Tepper","doi":"10.1111/J.1527-5299.2003.01904.X","DOIUrl":"https://doi.org/10.1111/J.1527-5299.2003.01904.X","url":null,"abstract":"","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"520 1","pages":"106-107"},"PeriodicalIF":0.0,"publicationDate":"2003-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80116848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Obstructive Sleep Apnea 阻塞性睡眠呼吸暂停
Pub Date : 2002-09-01 DOI: 10.1111/j.1527-5299.2002.01530.x
D. Tepper
Obstructive sleep apnea syndrome (OSA) is a highly prevalent disorder affecting approximately 4 to 10% of adults that has been implicated in a large spectrum of end-organ morbidities. OSA is characterized by repetitive obstructions of the upper airway during sleep that result in intermittent hypoxia (IH), increased inspiratory efforts, and ultimately sleep fragmentation (SF). A large body of research has extensively examined some of the mechanisms underlying the cardiovascular, cognitive, and metabolic co-morbidities associated with OSA in both patient cohorts and murine models. In this setting, activation and propagation of inflammatory and oxidative stress pathways have emerged as leading mechanistic processes.
阻塞性睡眠呼吸暂停综合征(OSA)是一种非常普遍的疾病,影响了大约4%至10%的成年人,与多种终末器官疾病有关。OSA的特征是睡眠期间上呼吸道反复阻塞,导致间歇性缺氧(IH)、吸气力增加,最终导致睡眠破碎(SF)。大量的研究已经在患者队列和小鼠模型中广泛检查了与OSA相关的心血管、认知和代谢合并症的一些潜在机制。在这种情况下,炎症和氧化应激途径的激活和传播已成为主要的机制过程。
{"title":"Obstructive Sleep Apnea","authors":"D. Tepper","doi":"10.1111/j.1527-5299.2002.01530.x","DOIUrl":"https://doi.org/10.1111/j.1527-5299.2002.01530.x","url":null,"abstract":"Obstructive sleep apnea syndrome (OSA) is a highly prevalent disorder affecting approximately 4 to 10% of adults that has been implicated in a large spectrum of end-organ morbidities. OSA is characterized by repetitive obstructions of the upper airway during sleep that result in intermittent hypoxia (IH), increased inspiratory efforts, and ultimately sleep fragmentation (SF). A large body of research has extensively examined some of the mechanisms underlying the cardiovascular, cognitive, and metabolic co-morbidities associated with OSA in both patient cohorts and murine models. In this setting, activation and propagation of inflammatory and oxidative stress pathways have emerged as leading mechanistic processes.","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"33 1","pages":"284-284"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75497902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Congestive heart failure
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1